Resources
Manuscripts & Publications
Nature Scientific Reports 2023 *(Submitted)
Immunogenicity of DaxibotulinumtoxinA for Injection in Facial Aesthetic Treatment.
Humphrey S., Dover J.S., Bowsher R.R., Clancy A., Prawdzik G., and Gallagher C.J.
Aesthetic Surgery Journal 2023
Noncompetitive immunoassay optimized for pharmacokinetic assessments of biologically active efruxifermin
Adam Kinne, Erik Tillman, Sanofar J. Abdeen, Derrick Johnson, Elijah Parmer, Jacob Hurst, Brittany de Temple, Sherri Rinker, Timothy Rolph, Ronald Bowsher
Journal of Pharmaceutical and Biomedical Analysis 2023
Assay development considerations to improve drug tolerance in direct competitive ligand binding neutralizing antibody assays, pretreatment strategies
Alok Rathi, Sherri Rinker, Hongmei Niu, Carina Carter, Seema Kumar, Kyra Cowen
Journal of Immunological Methods 2023
Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines Pooled Data from the SAKURA Phase 3 Trials
Conor J. Gallagher 1,*, Ronald R. Bowsher 2, Amanda Clancy 2, Jeffrey S. Dover 3, Shannon Humphrey 4, Yan Liu 1 and Gregg Prawdzik 1
Toxins 2023
Critical reagent inventory management system and web portal specifically optimized for supporting external clients
Jessica A Feauto, Aleks Davis, Sanofar J Abdeen, Hannah N Gill, Jamie E Colwell, Michael Chiappetta, Ronald R Bowsher
Bioanalysis 2022
Immunogenicity Manuscript: “An Integrated Analysis of Dostarlimab Immunogenicity”
Sharon Lu, Ronald R. Bowsher, Amanda Clancy, Amy Rosen, Mingxuan Zhang, Ying Yang, Kathleen Koeck, Minggeng Gao, Elizabeth Potocka, Wei Guo, Kai Yu Jen, Ellie Im & Ashley Milton
AAPS Journal 2021
Sensitive assay design for detection of anti-drug antibodies to biotherapeutics that lack an immunoglobulin Fc domain
Derrick Johnson, Erica Simmons, Sanofar Abdeen, Adam Kinne, Elijah Parmer, Sherri Rinker, Jennifer Thystrup, Swarna Ramaswamy & Ronald R. Bowsher
Nature Scientific Report 2021